With the opening of its Vienna campus, CEU is launching a thoroughly redesigned Executive MBA.
New results from researchers at the Centre for Pathobiochemistry and Genetics at the Medical University of Vienna show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer.
